International Biotechnology Trust PLC Cyma Bay Therapeutics, Inc. Transaction History

International Biotechnology Trust PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$6.54 - $11.74 $948,300 - $1.7 Million	-145,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$10.88 - $14.52 $794,240 - $1.06 Million	73,000 Added 101.39%	145,000 $1.23 Million
Q3 2018 Nov 13, 2018	SELL	$10.88 - $14.52 $794,240 - $1.06 Million	-73,000 Reduced 50.34%	72,000 $2.88 Million
Q4 2017 Mar 02, 2018	BUY	$7.67 - $9.31 $1.11 Million - $1.35 Million	145,000	145,000 $1.33 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.